Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Finalizes DRA Imaging Cuts; Stakeholders Hope For Legislative Fix

This article was originally published in The Gray Sheet

Executive Summary

Manufacturer and radiology groups are banking on legislation to reverse substantial cuts to physician imaging payments now that CMS has largely stuck with previously proposed payment drops in a fee schedule issued Nov. 1

You may also be interested in...



Imaging Procedure Volume Grows While Price Caps Cut Medicare’s Bill – GAO

Medicare spending on physician imaging services fell 12.7% to $12.1 billion in 2007 due to caps on related fees, despite an overall increase in imaging procedure volume, according to the U.S. Government Accountability Office

Imaging Procedure Volume Grows While Price Caps Cut Medicare’s Bill – GAO

Medicare spending on physician imaging services fell 12.7% to $12.1 billion in 2007 due to caps on related fees, despite an overall increase in imaging procedure volume, according to the U.S. Government Accountability Office

Going Grassroots In Health Debate: New AdvaMed Head Aims To Grow Base

The device lobby is trying to build a broader coalition in patient and physician communities to maximize its leverage during what could turn out to be the industry's most challenging period on the policy front in years

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel